Rabbit Recombinant Monoclonal HEPACAM antibody. Suitable for WB, ICC/IF and reacts with Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
IP | WB | IHC-P | ICC/IF | |
---|---|---|---|---|
Human | Not recommended | Tested | Not recommended | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/250 - 1/500 | Notes - |
Involved in regulating cell motility and cell-matrix interactions. May inhibit cell growth through suppression of cell proliferation (PubMed:15885354, PubMed:15917256). In glia, associates and targets CLCN2 at astrocytic processes and myelinated fiber tracts where it may regulate transcellular chloride flux involved in neuron excitability (PubMed:22405205).
Hepatic and glial cell adhesion molecule, glialCAM, Hepatocyte cell adhesion molecule, Protein hepaCAM, HEPACAM
Rabbit Recombinant Monoclonal HEPACAM antibody. Suitable for WB, ICC/IF and reacts with Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
HEPACAM also known as "glialCAM" is a transmembrane glycoprotein that weighs approximately 55-65 kDa. It primarily appears in the glial cells of the central nervous system and plays a significant role in cell adhesion and communication. Researchers identified this protein in astrocytes oligodendrocytes and ependymal cells. It interacts with other cell adhesion molecules to mediate interactions between glial cells and contributes to maintaining the structural integrity of tissues.
HEPACAM functions in the context of cell-cell adhesion and signal transduction mechanisms. This protein does not operate in isolation but rather forms part of larger protein complexes enhancing its role in cellular scaffolding and molecular signaling networks. The interaction with other cellular machinery supports processes like cell migration proliferation and differentiation which are critical for maintaining the homeostasis of neural tissues. Studies also highlight its role in modulating immune response and inflammatory processes within the nervous system.
HEPACAM integrates into specific pathways involving cellular adhesion and signal transduction such as the PI3K/AKT signaling pathway. This pathway plays an important role in controlling cell growth and survival. HEPACAM's interaction with molecules like integrins and other cell adhesion proteins strengthens its function within this pathway. For instance integrins contribute to the regulation of the extracellular matrix composition affecting cellular movements and interactions vital for immune surveillance and responses in the nervous system.
Research associates HEPACAM with conditions like epilepsy and leukodystrophy. Alterations in HEPACAM expression or function can lead to improper cell adhesion disrupting normal tissue architecture and contributing to pathological states. Additionally there are links between HEPACAM and connexins proteins involved in forming gap junctions which further emphasizes its role in conditions characterized by impaired cellular communication. These associations highlight HEPACAM's involvement in maintaining neural stability and function within the central nervous system.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Immunofluorescent analysis of HepG2 cells labeling HEPACAM with ab172635 at 1/250 dilution. DAPI nuclear staining (blue).
All lanes: Western blot - Anti-HEPACAM antibody [EPR11217] (ab172635) at 1/1000 dilution
Lane 1: Human fetal kidney lysate at 10 µg
Lane 2: Human fetal liver lysate at 10 µg
Lane 3: Human stomach lysate at 10 µg
Lane 4: Human fetal brain lysate at 10 µg
Predicted band size: 46 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com